Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-18-073894
Filing Date
2018-12-20
Accepted
2018-12-20 06:02:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a18-41849_1sc13da.htm SC 13D/A 131395
2 EX-7.04 a18-41849_1ex7d04.htm EX-7.04 29868
  Complete submission text file 0001104659-18-073894.txt   162927
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filed by) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D/A

Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Subject) CIK: 0001636050 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-88883 | Film No.: 181244568
SIC: 2834 Pharmaceutical Preparations